A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 38/21 (2006.01)
Patent
CA 2185892
Trophoblastic .beta.-I-glycoprotein (TBG) is used as a means for treating autoimmune diseases showing suppressors immunodeficit. A method of treating of autoimmune diseases comprises the administration of an immune correcting preparation, said preparation being trophoblastic .beta.-I-glycoprotein (TBG), indications wlth respect to said preparation being determined by testing TBG sensitivity of mononuclear cells (MNCs).
L'agent thérapeutique proposé contre les maladies auto-immunes caractérisées par un déficit immunitaire en cellules suppressives est la glycoprotéine béta-1 trophoblastique. La thérapie proposée contre ces maladies auto-immunes comprend l'administration d'un agent immunocorrecteur, notamment, la glycoprotéine béta-1 trophoblastique; on obtient les indicateurs pour l'utilisation de cet agent en testant la sensibilité des cellules mononucléaires à la glycoprotéine béta-1 trophoblastique.
Alikhanov Khallar Abdumuslimovich
Golovistikov Ivan Nikolaevich
Kacharava Leonid Yazonovich
Tatarinov Jury Semyonovich
Alikhanov Khallar Abdumuslimovich
Golovistikov Ivan Nikolaevich
Kacharava Leonid Yazonovich
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Tatarinov Jury Semyonovich
LandOfFree
Means for treating auto-immune diseases and method of treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Means for treating auto-immune diseases and method of treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means for treating auto-immune diseases and method of treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1500345